Literature DB >> 25074877

Is posterior reversible encephalopathy syndrome really reversible? Autopsy findings 4.5 years after radiographic resolution.

Cyril Jacquot, Christine M Glastonbury, Tarik Tihan.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is defined by a spectrum of clinical symptoms and characteristic radiologic findings. Most patients show clinical recovery and normalization of imaging, even though a subset of rare cases may progress to cytotoxic edema, irreversible damage, and persistent radiological findings. As the condition is transient and seldom leads to death, few reports of pathologic findings during an acute episode or in patients following a resolved episode are available. Here, we describe the neuropathologic findings at autopsy in a 62-year-old woman with a history of systemic lupus erythematosus (SLE) and an episode of PRES that had resolved radiologically and clinically ~ 4.5 years prior to death. Autopsy findings included diffuse rarefaction of white matter with scattered microinfarcts, subpial gliosis, as well as perivascular lymphocytic aggregates and hemosiderin deposition in the sections from the posterior cerebrum. Some but not all of these changes of chronic white matter damage may be attributed to the coexisting systemic lupus erythematosus. Thus, we conclude that pathologic evidence of partial irreversible damage can be documented in PRES in spite of radiographic resolution of abnormalities.

Entities:  

Mesh:

Year:  2015        PMID: 25074877     DOI: 10.5414/NP300771

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  4 in total

1.  Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels.

Authors:  B Gao; B X Yu; R S Li; G Zhang; H Z Xie; F L Liu; C Lv
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-02       Impact factor: 3.825

2.  Uremic Encephalopathy: MR Imaging Findings and Clinical Correlation.

Authors:  D M Kim; I H Lee; C J Song
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-28       Impact factor: 3.825

Review 3.  New Developments in Hypertensive Encephalopathy.

Authors:  Joseph B Miller; Kushak Suchdev; Namita Jayaprakash; Daniel Hrabec; Aditya Sood; Snigdha Sharma; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

4.  Posterior reversible encephalopathy syndrome in stroke-prone spontaneously hypertensive rats on high-salt diet.

Authors:  Fanny Herisson; Iris Zhou; Jerome Mawet; E Du; Arnavaz H Barfejani; Tao Qin; Marilyn J Cipolla; Philip Z Sun; Natalia S Rost; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-19       Impact factor: 6.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.